- Home
- ANTX
as 04-18-2025 1:30pm EST
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | MENLO PARK |
| Market Cap: | 41.2M | IPO Year: | 2022 |
| Target Price: | $3.50 | AVG Volume (30 days): | 79.8K |
| Analyst Decision: | Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.72 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.87 - $3.07 | Next Earning Date: | 05-13-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest AN2 Therapeutics Inc. News
ANTX Breaking Stock News: Dive into ANTX Ticker-Specific Updates for Smart Investing
Simply Wall St.
12 days ago
Here's Why We're Watching AN2 Therapeutics' (NASDAQ:ANTX) Cash Burn Situation
Business Wire
2 months ago
AN2 Therapeutics to Present at Leerink Partners Global Healthcare Conference
Simply Wall St.
2 months ago
Golden Sun Health Technology Group Leads 3 US Penny Stocks Worth Monitoring
Business Wire
2 months ago
AN2 Provides Strategic Update for Phase 3 EBO-301 Trial in Treatment Refractory MAC Lung Disease
Business Wire
2 months ago
AN2 Therapeutics to Participate at Upcoming Investor Conferences
Business Wire
3 months ago
AN2 Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Simply Wall St.
3 months ago
Favourable Signals For AN2 Therapeutics: Numerous Insiders Acquired Stock
Simply Wall St.
5 months ago
Immuneering Leads The Pack Of 3 US Penny Stocks To Monitor
Compare ANTX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ANTX AN2 Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.